Ripertamab API Manufacturers

compare suppliers & get competitive offers

Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.

Want to be the first to find out when a supplier for Ripertamab is listed?

Join our notification list by following this page.

Are you a supplier of Ripertamab or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

LEARN MORE

Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

LEARN MORE

Looking for Ripertamab API 2249927-04-4?

Description:: Here you will find a list of producers, manufacturers and distributors of Ripertamab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:: Ripertamab
Synonyms:: Immunoglobulin g1-kappa, anti-(homo sapiens ms4a1 (membrane-spanning 4-domains subfamily a member 1, cd20)), chimeric monoclonal antibody , Immunoglobulin igg1, anti-(human cd20 antigen) (human-mus musculus monoclonal disulfide sct400 .gamma.1-chain), disulfide with human-mus musculus monoclonal sct400 .kappa.-chain, dimer , Ripertamab
Cas Number:: 2249927-04-4
DrugBank number:: DB16314
Unique Ingredient Identifier:: URS0374MIV

General Description:

Ripertamab, identified by CAS number 2249927-04-4, is a notable compound with significant therapeutic applications. Ripertamab is under investigation in clinical trial NCT02772822 (A Study Comparing the Efficiency and Safety of S-chop(cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated Cd20(cluster of Differentiation Antigen 20)-positive DLBCL Patients).